Skip to content

EMDR Flash Forward as an intervention on the mental images of worst case scenarios in paranoid delusions

EMDR Flash Forward as an intervention on the mental images of worst case scenarios in paranoid delusions - EMDR Flash Forward in delusions

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON52712
Enrollment
40
Registered
2020-05-11
Start date
2020-10-07
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paranoid delusions suspicious anxiety

Interventions

Participants are treated for 6 weeks, once a week, with EMDR Flash Forward, a variant of EMDR (Eye Movement Desensitization and Reprocessing), focused on the worst case scenarios associated with the

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
16 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. The participants have been diagnosed with schizophrenia spectrum disorder, with paranoid delusions as a core symptom (DSM-V). 2. A score on the Psyrats DRS of> 15. 3. The age must be between 16 and 60 years. 4. Prescribed medication for the treatment of psychosis must be stable for at least a month. 5. A comorbid diagnosis of PTSD must have been treated adequately and symptoms must be in remission.

Exclusion criteria

Exclusion criteria: 1. Participants who still have to be adjusted to appropriate antipsychotic medication. 2. Participants with serious dissociative symptoms. 3. Participants with an alcohol or substance dependency 4. Participants with organic syndrome, learning disability, or severe visual impairments. 5. Participants who are already following a different psychological treatment aimed at delusions. 6. Participants who have insufficient understanding of the Dutch language. 7. Participants who are suicidal.

Design outcomes

Primary

MeasureTime frame
The primary studyparameter is the Psychotic Symptoms, Delusion Rating Scale (Psyrats DRS), where it is expected that the (negative) difference score on the Psyrats DRS between start waiting list and end waiting list will be lower than between start treatment and end treatment.

Secondary

MeasureTime frame
The Safety Behavior Questionnaire (SBQ) is administered, whereby it is expected that the score on the SBQ at the start of the waiting list will be higher than at the end of the treatment and even higher at the follow-up.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)